Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/15/13 → 4/15/16 |
Funding
- Boehringer Ingelheim Pharmaceuticals, Inc. (Prot #1241.36)
Prot #1241.36: A Phase III Randomised, Partially Double-Blind and Placebo-Controlled Study of BI 207127 in Combination with Faldaprevir and Ribavirin for Chronic Genotype 1 Hepatitis C Infection in an Extended Population of Treatment Naïve Patients that I
- Flamm, Steven L (PD/PI)
Project: Research project